logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Lates News

date
30/05/2025
C3.AI rose more than 10% after hours.
Latest
2 m ago
Brain-computer interface concept anomaly rose, innovative medical straight-line limit up.
3 m ago
Sino-Science Vanguard opened significantly lower in early trading, falling about 14% at one point, and currently down more than 10%. Earlier, Sino-Science Vanguard announced that it has been suspended from participating in military supplies procurement activities.
5 m ago
Shutai Shen continued to rise sharply in early trading, with a gain of over 14%; Shutai Shen announced that the company had noticed the high level of attention in the market to the information about the "Priority Review Variety Publicity" column on the website of the Drug Evaluation Center of the National Medical Products Administration about the application of the company's controlling subsidiary Jiangsu Beijetai Biological Technology Co., Ltd. for "Injection STSP-0601"; the drug is currently in the public notice period, with the deadline for public notice being June 3, 2025. There is still a lot of uncertainty about whether the drug will enter the priority review process after the public notice period expires.
6 m ago
In terms of concept, EDA experienced a majority callback, Huada Jiutian fell by nearly 6%, while Guangli Micro, Taichi Stock, and Galen Electronics all dropped by more than 3%.
7 m ago
Stock prices plunged after trading hours! Gap (GAP.US) warned that tariffs may eat away 300 million in profits.
See all latestmore
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.